Mark Throdahl - Orthopediatrics Corp President CEO, Director
| KIDS Stock | USD 25.98 0.59 2.32% |
CEO
Mr. Mark C. Throdahl is President, Chief Executive Officer, Director of the Company. Prior to joining our company, Mr. Throdahl served from 2008 to 2009 as a Group President of Zimmer Holdings, Inc., a worldwide leader in orthopedic implants. Mr. Throdahl previously served from 2001 to 2007 as the Chief Executive Officer and Director of Consort Medical plc in London, United Kingdom. During a 13 year career at Becton Dickinson Co., he served as Senior Vice President of the Drug Delivery sector and President of Nippon Becton Dickinson in Tokyo. Mr. Throdahl began his career at Mallinckrodt, Inc since 2011.
| Age | 73 |
| Tenure | 13 years |
| Professional Marks | MBA |
| Address | 2850 Frontier Drive, Warsaw, IN, United States, 46582 |
| Phone | 574 268 6379 |
| Web | https://www.orthopediatrics.com |
Mark Throdahl Latest Insider Activity
Tracking and analyzing the buying and selling activities of Mark Throdahl against Orthopediatrics Corp stock is an integral part of due diligence when investing in Orthopediatrics Corp. Mark Throdahl insider activity provides valuable insight into whether Orthopediatrics Corp is net buyers or sellers over its current business cycle. Note, Orthopediatrics Corp insiders must abide by specific rules, including filing SEC forms every time they buy or sell Orthopediatrics Corp'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Mark Throdahl over a year ago Acquisition by Mark Throdahl of 12266 shares of Orthopediatrics Corp subject to Rule 16b-3 | ||
Mark Throdahl over a year ago Sale by Mark Throdahl of 4515 shares of Orthopediatrics Corp |
Orthopediatrics Corp Management Efficiency
The company has return on total asset (ROA) of (0.0394) % which means that it has lost $0.0394 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0763) %, meaning that it created substantial loss on money invested by shareholders. Orthopediatrics Corp's management efficiency ratios could be used to measure how well Orthopediatrics Corp manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.08 in 2024. Return On Capital Employed is likely to drop to -0.07 in 2024. At this time, Orthopediatrics Corp's Asset Turnover is comparatively stable compared to the past year.Similar Executives
| Found 12 records | CEO Age | ||
| Vladimir Makatsaria | LivaNova PLC | 51 | |
| Joel Becker | Neuropace | 56 | |
| Kathleen Skarvan | Electromed | 68 | |
| Albert DaCosta | Paragon 28 | 51 | |
| Quentin Blackford | iRhythm Technologies | 45 | |
| Nadim Yared | CVRx Inc | 56 | |
| Damien McDonald | LivaNova PLC | 59 | |
| Glendon French | Pulmonx Corp | 62 | |
| Massimo Calafiore | Orthofix Medical | 52 | |
| Kevin Hykes | CVRx Inc | 58 | |
| Steven Williamson | Pulmonx Corp | 51 | |
| Gary Maharaj | SurModics | 61 | |
Management Performance
| Return On Equity | -0.0763 | ||||
| Return On Asset | -0.0394 |
Orthopediatrics Corp Leadership Team
Elected by the shareholders, the Orthopediatrics Corp's board of directors comprises two types of representatives: Orthopediatrics Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Orthopediatrics. The board's role is to monitor Orthopediatrics Corp's management team and ensure that shareholders' interests are well served. Orthopediatrics Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Orthopediatrics Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Daniel JD, General Legal | ||
| MBAMSHA CHE, President Technologies | ||
| Daniel Gerritzen, General Counsel and Vice President of Legal and Human Resources | ||
| Joel Batts, Senior Affairs | ||
| David Bailey, Executive Vice President | ||
| Mark Throdahl, President CEO, Director | ||
| Fred Hite, CFO, Director | ||
| Joseph Hauser, President Correction | ||
| Gregory Odle, Executive Vice President | ||
| Mark Karshner, Senior Sales |
Orthopediatrics Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Orthopediatrics Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0763 | ||||
| Return On Asset | -0.0394 | ||||
| Profit Margin | (0.15) % | ||||
| Operating Margin | (0.10) % | ||||
| Current Valuation | 611.45 M | ||||
| Shares Outstanding | 24.22 M | ||||
| Shares Owned By Insiders | 32.52 % | ||||
| Shares Owned By Institutions | 70.85 % | ||||
| Number Of Shares Shorted | 801.13 K | ||||
| Price To Earning | (10.06) X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Orthopediatrics Stock Analysis
When running Orthopediatrics Corp's price analysis, check to measure Orthopediatrics Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthopediatrics Corp is operating at the current time. Most of Orthopediatrics Corp's value examination focuses on studying past and present price action to predict the probability of Orthopediatrics Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthopediatrics Corp's price. Additionally, you may evaluate how the addition of Orthopediatrics Corp to your portfolios can decrease your overall portfolio volatility.